查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947279

智慧仿生寵物市場（按動物類型、技術、仿生技術和最終用戶分類），全球預測，2026-2032年

Intelligent Bionic Pet Market by Animal Type, Technology, Bionics Technology, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，智慧仿生寵物市場價值將達到 2.8547 億美元，到 2026 年將成長至 3.3161 億美元，到 2032 年將達到 8.8547 億美元，複合年成長率為 17.55%。

關鍵市場統計數據
基準年 2025 2.8547億美元
預計年份：2026年 3.3161億美元
預測年份 2032 8.8547億美元
複合年成長率 (%) 17.55%

為智慧仿生寵物領域建立清晰的框架，整合技術進步、與獸醫學的合作以及商業性應用趨勢。

智慧仿生寵物領域融合了獸醫學、機器人技術和寵物消費護理，重新定義了動物福利、行動能力和感官功能的理念。輕型致動器、緊湊型電源系統和微型感測器的發展，正為行動不便、感官障礙或需要特殊服務的寵物帶來實際的解決方案。隨著產品原型逐漸成熟並最終走向商業化，從獸醫診所到專業零售商等各方相關人員都在探索一個不斷發展的設備認證、臨床檢驗和用戶採納生態系統。

技術、臨床、監管和分銷趨勢的匯合正在重新定義智慧仿生寵物領域的產品開發和應用。

智慧仿生寵物領域正經歷多個轉折點，這些轉折點正在改變產品的開發、檢驗和上市方式。感測器小型化和機器學習技術的進步使得設備能夠適應個別動物的行為，從而提升舒適度和功能效果。同時，工程師和獸醫專業人員之間的跨學科合作提高了臨床證據和人性化設計的標準，使設備更容易被專業人士和寵物飼主接受。

為因應智慧仿生寵物價值鏈中累積的關稅壓力，各企業正採取策略性因應措施，重塑供應商選擇、製造地和定價策略。

關稅政策和貿易措施將對智慧仿生寵物產業的製造商和經銷商的供應鏈、採購和定價策略產生重大影響。近期關稅調整迫使企業重新評估其供應商基礎，實現零件採購多元化，並考慮將生產外包或在地化生產，以降低跨境成本波動的風險。這些策略轉變通常需要重新評估庫存管理，調整與供應商的合約條款，並投入資金在靠近關鍵市場的地方建立替代生產線。

透過對動物種類、設備技術、通路、最終用戶和價格點進行綜合分析，建構一個精細的市場區隔模型，從而為產品設計和市場推廣策略提供切實可行的建議。

深入的細分分析揭示了動物類型、仿生技術、分銷管道、終端用戶和價格點的哪些組合正在驅動不同的需求和採用模式。對貓和狗的物種差異檢驗，可以發現它們在人體工學和行為設計方面有顯著差異。貓分為室內貓、室外貓和寵物貓三類，通常需要輕巧靈活的外形和隱藏的安裝系統以保持靈活性。而狗則分為寵物狗、服務犬和工作犬三類，它們通常需要高承重能力、柔軟性和特定任務的介面。

區域趨勢和營運需求決定了產品在美洲、歐洲、中東和非洲以及亞太市場的相關性、臨床參與度和分銷策略。

區域趨勢正在影響關鍵地區的產品優先順序、監管方式和通路開發，為智慧仿生寵物領域的企業帶來獨特的機會和挑戰。在美洲，消費者在寵物健康方面的強勁支出和完善的獸醫服務網路推動了高階設備的普及和臨床應用，而區域監管差異和物流複雜性則促使企業投資於本地夥伴關係和客製化服務項目。區域內的跨境貿易凸顯了統一的品質標準和可互通的服務體系對於高效能業務拓展的重要性。

領先的製造商和服務供應商如何將技術差異化、臨床檢驗和服務生態系統結合，打造可擴展的競爭優勢

推動智慧仿生寵物市場發展的主要企業，將工程技術專長、獸醫合作和可擴展的服務模式相結合，以提供差異化的價值提案。領先的創新者優先進行多學科研究和臨床夥伴關係，以檢驗設備的安全性和有效性，並投資於以使用者為中心的設計和迭代測試，以提高動物和看護者的接受度。這些公司的策略重點領域包括：降低客製化成本的模組化硬體架構、支援遠端調整的整合式遠端監控解決方案，以及管理安裝、維護和備件供應的持久服務生態系統。

為經營團隊提供一條切實可行的實施路徑，以建立具有韌性的供應鏈、臨床證據和全通路服務模式，從而推動永續應用。

產業領導者應優先採取一系列切實可行的措施，在管控風險的同時，將策略意圖轉化為市場認可。首先，組成跨職能團隊，整合工程、獸醫學和客戶體驗設計等領域，以加快迭代速度，縮短以人為本和以動物為中心的產品的市場接受度。其次，實現供應鏈多元化，探索區域組裝方案，以降低貿易中斷和關稅相關成本波動帶來的風險，並透過嚴格的供應商篩選來確保產品品質。

嚴謹的多源調查方法，整合了原始臨床數據、技術評估和二手研究，以產生可操作的、以福祉為中心的見解。

本分析的調查方法融合了定性訪談、文獻綜述和技術評估，旨在從技術、臨床和商業三個領域對資訊進行三角驗證。主要研究包括對獸醫、產品設計師、復健專家和通路合作夥伴進行結構化訪談，以收集關於設備適配性、用戶接受度和售後服務的第一手資訊。這些訪談揭示了實際應用中的限制因素和潛在機遇，尤其是在人體工學、行為相容性和服務需求方面。

本文從福利、證據和營運成熟度三個面向，全面觀點了智慧仿生解決方案永續應用的條件。

智慧仿生寵物領域正從實驗性創新轉向以服務為導向的實用產品，旨在改善動物福利並增強其功能。這個進程將取決於工程師、獸醫、監管相關人員和商業夥伴之間的持續合作，將安全性、有效性和倫理責任融入產品生命週期。那些能夠顯著改善動物活動能力和感官功能，同時透過可維護的設計和靈活的分銷模式，使之能夠被廣大終端用戶所接受的解決方案，將更容易被市場接受。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依動物類型分類的智慧仿生寵物市場

  • 貓
  • 狗

9. 科技驅動的智慧仿生寵物市場

  • 仿生增強
  • 連接/智慧功能
  • 移動/驅動機構
  • 感覺功能/互動

第10章 仿生技術引領的智慧仿生寵物市場

  • 外骨骼
  • 提高行動能力
  • 感覺擴展

第11章 智慧仿生寵物市場（以終端用戶分類）

  • 消費者/家庭
  • 教育/娛樂
  • 老年護理
  • 服務/工作動物使用案例

第12章 各區域的智慧仿生寵物市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 智慧仿生寵物市場（依群體分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國智慧仿生寵物市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國智慧仿生寵物市場

第16章：中國的智慧仿生寵物市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ANYbotics AG
  • Bionic Pets
  • Boston Dynamics
  • DEEP Robotics
  • Ghost Robotics Corporation
  • Hiwonder
  • Intuition Robotics Ltd.
  • Petoi Technology Co., Ltd.
  • Sony Group Corporation
  • Sure Petcare Limited
  • Tombot, Inc.
  • Tomofun Ltd.
  • Unitree Robotics Co., Ltd.
  • WEILAN Co., Ltd.
  • Whistle Labs, Inc.
  • WowWee Group Limited
  • Xiaomi Inc
Product Code: MRR-4F7A6D4FB660

The Intelligent Bionic Pet Market was valued at USD 285.47 million in 2025 and is projected to grow to USD 331.61 million in 2026, with a CAGR of 17.55%, reaching USD 885.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 285.47 million
Estimated Year [2026] USD 331.61 million
Forecast Year [2032] USD 885.47 million
CAGR (%) 17.55%

A clear framing of the intelligent bionic pet landscape that synthesizes technological advances, veterinary collaboration, and commercial adoption dynamics

The Intelligent Bionic Pet sector represents a convergence of veterinary medicine, robotics, and consumer pet care that is redefining how animal welfare, mobility, and sensory capabilities are addressed. Developments in lightweight actuators, compact power systems, and miniaturized sensors have translated into practical solutions for pets with mobility impairments, sensory deficits, or specialized service roles. As product prototypes mature into commercial offerings, stakeholders from veterinary clinics to specialty retailers are navigating an evolving ecosystem of device certification, clinical validation, and user adoption.

Emerging designs prioritize animal comfort, ergonomic fit, and non-invasive interfaces, reflecting informed collaboration between engineers, veterinarians, and animal behaviorists. This interdisciplinary approach has improved acceptance rates among pets and increased owner confidence in adopting advanced assistive technologies. At the same time, supply chain innovation and digital distribution channels are changing how products are introduced to owners and professionals, enabling more tailored fitting services, telehealth-enabled follow-up, and modular upgrades that extend device utility over time.

Transitioning from concept to routine care requires attention to regulatory pathways, clinical outcomes, and ethical considerations. Stakeholders must reconcile rapid technological progress with robust safety testing and transparent efficacy evidence to build long-term trust. Consequently, decision-makers should view the Intelligent Bionic Pet opportunity as a long-term transformation of care models rather than a short-term product play.

How converging technological, clinical, regulatory, and distribution trends are redefining product development and adoption in the intelligent bionic pet sector

Several transformative shifts are reshaping the Intelligent Bionic Pet landscape, altering how products are developed, validated, and brought to market. Advances in sensor miniaturization and machine learning have enabled devices that adapt behaviorally to individual animals, improving comfort and functional outcomes. Concurrently, cross-disciplinary partnerships between engineers and veterinary clinicians have elevated the standard for clinical evidence and humane design, making devices more acceptable to both professionals and pet owners.

Supply chain resilience and modular manufacturing approaches have reduced lead times for specialized components, while the rise of direct-to-consumer and hybrid distribution models has expanded routes to end users beyond traditional clinical channels. Regulatory frameworks are also adapting; while standards continue to vary across jurisdictions, there is a notable trend toward clearer guidance on animal-assistive devices, fostering greater investment in clinical trials and post-market surveillance. Ethical considerations around animal welfare, user consent, and data privacy are attracting attention from advocacy groups and professional bodies, prompting manufacturers to embed transparency and traceability into product lifecycles.

Taken together, these shifts are creating a more credible, scalable ecosystem for intelligent bionic applications in animals, where sustained adoption will hinge on measurable outcomes, cost-effective servicing models, and collaborative stakeholder engagement.

Strategic responses to cumulative tariff pressures that reshape supplier sourcing, manufacturing footprints, and pricing strategies across the intelligent bionic pet value chain

Tariff policies and trade measures can materially influence supply chains, component sourcing, and pricing strategies for manufacturers and distributors operating in the Intelligent Bionic Pet space. Recent tariff adjustments have prompted companies to reassess supplier footprints, diversify component sourcing, and consider nearshoring or regional manufacturing to mitigate exposure to cross-border cost volatility. These strategic shifts often require recalibration of inventory management, contractual terms with suppliers, and capital allocation to set up alternate production lines closer to key markets.

In response, procurement teams are prioritizing supplier resilience and dual-sourcing arrangements for critical components such as actuators, battery modules, and specialized sensors. Companies that previously relied on single-source overseas suppliers are now exploring partnerships with regional manufacturers and contract assemblers to reduce tariff-related margin pressures. These operational changes also affect aftersales service networks, spare parts logistics, and warranty planning, necessitating tighter integration between manufacturing and customer service teams.

From a commercial perspective, pricing strategies must account for tariff-induced cost differentials while remaining competitive and accessible to end users. Manufacturers that proactively restructure supply chains to absorb tariff impacts through efficiency gains, redesigns for component standardization, or localized assembly stand a better chance of preserving margins and maintaining market momentum. Ultimately, understanding the cumulative implications of tariff changes is essential for leadership teams planning capital investment, partner selection, and long-term distribution strategies.

Nuanced segmentation analysis that connects animal types, device technologies, channels, end users, and price tiers to actionable design and go-to-market implications

Insightful segmentation illuminates which combinations of animal types, bionics technologies, distribution channels, end users, and price ranges are driving differentiated requirements and adoption patterns. Examining animal type distinctions among cats and dogs reveals divergent ergonomic and behavioral design imperatives; cats, differentiated into indoor cats, outdoor cats, and pet cats, typically demand lighter, more flexible form factors and unobtrusive attachment systems to preserve agility, whereas dogs, segmented into pet dogs, service dogs, and working dogs, often require higher load capacity, ruggedization, and task-specific interfaces.

Bionics technology delineations between exoskeletons, mobility enhancement, and sensory augmentation indicate varied engineering priorities. Mobility enhancement subdivides into joint actuators and limb prosthetics, each with distinct biomechanical control challenges and fitting workflows, while sensory augmentation breaks into auditory sensors, olfactory sensors, and visual sensors, which impose different signal processing, power, and feedback requirements. Distribution channels spanning online retail, specialty stores, and veterinary clinics create contrasting customer touchpoints; online channels emphasize digital education, remote fitting support, and convenient replenishment, specialty stores provide hands-on demonstrations and personalized fittings, and veterinary clinics integrate clinical assessment, prescription-like workflows, and post-procedural follow-up.

End users categorized as household, professional, and research reflect demand drivers that range from quality-of-life enhancements for pet owners to performance and certification requirements for service or working animals, and experimental validation needs for research institutions. Price range segmentation into high, low, and mid tiers underscores the trade-offs between advanced capabilities, custom fitting services, and accessibility. Understanding the interplay of these segments enables more precise product design, channel strategies, and service models that address the specific expectations and constraints of each cohort.

Regional dynamics and operational imperatives that determine product-fit, clinical engagement, and distribution strategies across Americas, EMEA, and Asia-Pacific markets

Regional dynamics shape product prioritization, regulatory approaches, and channel development across key geographies, yielding distinct opportunities and constraints for companies in the intelligent bionic pet space. In the Americas, strong consumer spending on pet health and established veterinary networks favor adoption of premium devices and clinical integration, but regional regulatory variability and logistics complexity encourage firms to invest in local partnerships and tailored service programs. Cross-border trade within the region also highlights the importance of harmonized quality standards and interoperable servicing arrangements to scale efficiently.

In Europe, Middle East & Africa, diverse regulatory regimes and rising demand for animal welfare-oriented solutions coexist with a cautious reimbursement environment, prompting manufacturers to emphasize clinical evidence and cost-effectiveness. Fragmented markets within the region necessitate adaptable distribution models, strong relationships with veterinary associations, and region-specific training for fitting specialists. Cultural differences in pet ownership and use of working animals further influence product form factors and communication strategies.

Asia-Pacific presents a mix of rapid urban pet ownership growth, increasing spending on premium pet products, and a dynamic manufacturing ecosystem that can support component sourcing and local assembly. Market entrants here benefit from partnerships with established veterinary networks and specialty retailers, while also navigating heterogeneous regulatory landscapes across countries. Across all regions, companies that align product design, evidence generation, and service delivery with local expectations and regulatory requirements will be better positioned to convert interest into sustained adoption.

How leading manufacturers and service providers combine technical differentiation, clinical validation, and service ecosystems to establish scalable competitive advantage

Key companies shaping the Intelligent Bionic Pet landscape combine engineering expertise, veterinary collaboration, and scalable service models to deliver differentiated value propositions. Leading innovators prioritize interdisciplinary research and clinical partnerships to validate device safety and efficacy, investing in user-centric design and iterative testing to improve acceptance among animals and caretakers. Strategic focus areas for these companies include modular hardware architectures that lower customization costs, integrated telemonitoring solutions to support remote adjustments, and durable service ecosystems to manage fittings, maintenance, and spare parts availability.

Competitive positioning often rests on intellectual property around actuator miniaturization, adaptive control algorithms, and sensor fusion techniques that enable naturalistic movement and reliable environmental sensing. At the same time, successful firms pay close attention to commercial execution, building relationships with veterinary networks, specialty retailers, and rehabilitation centers to create trusted referral pathways. Partnerships with research institutions and human-medical device suppliers can accelerate component innovation while also raising standards for clinical validation. Ultimately, companies that align technical differentiation with robust go-to-market systems and service capabilities will lead in establishing repeatable, scalable adoption among pet owners and professionals.

Actionable implementation pathways for executives to build resilient supply chains, clinical evidence, and omnichannel service models that drive sustainable adoption

Industry leaders should prioritize a set of pragmatic actions to convert strategic intent into market traction while managing risk. First, embed cross-functional teams that pair engineering, veterinary science, and customer experience design to accelerate human-animal-centered product iterations and reduce time-to-acceptance. Second, diversify supply chains and explore regional assembly options to reduce exposure to trade disruptions and tariff-related cost variability, while preserving manufacturing quality through rigorous supplier qualification.

Third, invest in clinical evidence generation and transparent outcome reporting to build trust with veterinarians, pet owners, and regulators; these data can also support premium positioning and informed reimbursement discussions. Fourth, develop flexible distribution models that combine online education and remote fitting services with in-person clinical and specialty retail touchpoints to meet distinct customer preferences. Fifth, design serviceable, modular products that simplify maintenance, enable upgrades, and lower total cost of ownership for end users. Finally, actively engage with professional associations, animal welfare organizations, and ethical review bodies to shape responsible use standards, data governance practices, and post-market surveillance frameworks that protect animal welfare and brand reputation.

Collectively, these actions create a resilient foundation for sustainable growth, balancing innovation velocity with the operational and ethical rigor required to win trust across stakeholders.

A rigorous multi-source methodology synthesizing primary clinical input, technical assessments, and secondary research to produce practical, welfare-focused insights

The research methodology underpinning this analysis integrates primary qualitative interviews, secondary literature review, and technology assessment to triangulate insights across technical, clinical, and commercial domains. Primary engagements included structured interviews with veterinary clinicians, product designers, rehabilitation specialists, and channel partners to capture firsthand experience with device fitting, user acceptance, and aftercare logistics. These conversations informed real-world constraints and opportunity areas, particularly around ergonomics, behavioral compatibility, and servicing requirements.

Secondary sources encompassed peer-reviewed veterinary and biomedical engineering literature, patent landscape scans, product technical specifications, and industry thought leadership to validate technological trajectories and identify engineering trade-offs. Technology assessments focused on actuator technologies, sensor modalities, power management approaches, and control algorithms to understand capability ceilings and integration complexity. Throughout the methodology, attention was given to ethical considerations and animal welfare standards, ensuring that recommended design and commercialization approaches align with accepted care principles.

Synthesis prioritized convergent themes across data sources, emphasizing replicable findings such as the importance of interdisciplinary design, the operational impact of supply chain shifts, and the need for robust clinical validation. This layered approach enabled the development of actionable recommendations that are grounded in practical experience and technical feasibility.

Summative perspective on the conditions for enduring adoption of intelligent bionic solutions centered on welfare, evidence, and operational maturity

The Intelligent Bionic Pet domain is transitioning from experimental innovation toward practical, service-oriented offerings that enhance animal welfare and extend functional capability. Progress hinges on sustained collaboration among engineers, veterinarians, regulatory stakeholders, and commercial partners to embed safety, efficacy, and ethical stewardship into product lifecycles. Adoption will favor solutions that deliver measurable improvements in mobility or sensory function while remaining affordable to a broad spectrum of end users through serviceable designs and adaptable distribution models.

Leaders that combine technical excellence with operational resilience and clear evidence of benefit will set the standard for long-term value creation. Regulatory clarity, regional market adaptation, and strong aftercare ecosystems are each critical to converting early interest into routine clinical and consumer practice. As the field matures, the companies that balance humane design, robust validation, and scalable servicing will define the norms for how intelligent bionic solutions are integrated into everyday care for companion and working animals alike.

In sum, the opportunity is substantial but conditional: success depends on rigorous attention to animal welfare, pragmatic supply chain strategies, and the generation of trusted clinical evidence to underpin sustainable adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intelligent Bionic Pet Market, by Animal Type

  • 8.1. Cats
  • 8.2. Dogs

9. Intelligent Bionic Pet Market, by Technology

  • 9.1. Bionic Enhancements
  • 9.2. Connectivity / Smart Features
  • 9.3. Mobility / Actuation
  • 9.4. Sensory / Interaction

10. Intelligent Bionic Pet Market, by Bionics Technology

  • 10.1. Exoskeleton
  • 10.2. Mobility Enhancement
  • 10.3. Sensory Augmentation

11. Intelligent Bionic Pet Market, by End-User

  • 11.1. Consumer/Home Use
  • 11.2. Educational / Entertainment
  • 11.3. Senior Care
  • 11.4. Service / Working Animal Use-Case

12. Intelligent Bionic Pet Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intelligent Bionic Pet Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intelligent Bionic Pet Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Intelligent Bionic Pet Market

16. China Intelligent Bionic Pet Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. ANYbotics AG
  • 17.6. Bionic Pets
  • 17.7. Boston Dynamics
  • 17.8. DEEP Robotics
  • 17.9. Ghost Robotics Corporation
  • 17.10. Hiwonder
  • 17.11. Intuition Robotics Ltd.
  • 17.12. Petoi Technology Co., Ltd.
  • 17.13. Sony Group Corporation
  • 17.14. Sure Petcare Limited
  • 17.15. Tombot, Inc.
  • 17.16. Tomofun Ltd.
  • 17.17. Unitree Robotics Co., Ltd.
  • 17.18. WEILAN Co., Ltd.
  • 17.19. Whistle Labs, Inc.
  • 17.20. WowWee Group Limited
  • 17.21. Xiaomi Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTELLIGENT BIONIC PET MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTELLIGENT BIONIC PET MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY BIONIC ENHANCEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY BIONIC ENHANCEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY BIONIC ENHANCEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONNECTIVITY / SMART FEATURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONNECTIVITY / SMART FEATURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONNECTIVITY / SMART FEATURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY / ACTUATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY / ACTUATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY / ACTUATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY / INTERACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY / INTERACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY / INTERACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EXOSKELETON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EXOSKELETON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EXOSKELETON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY AUGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY AUGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY AUGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONSUMER/HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONSUMER/HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONSUMER/HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EDUCATIONAL / ENTERTAINMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EDUCATIONAL / ENTERTAINMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EDUCATIONAL / ENTERTAINMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENIOR CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENIOR CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENIOR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SERVICE / WORKING ANIMAL USE-CASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SERVICE / WORKING ANIMAL USE-CASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SERVICE / WORKING ANIMAL USE-CASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS INTELLIGENT BIONIC PET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 76. AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASEAN INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 92. GCC INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GCC INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. GCC INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. GCC INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. GCC INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPEAN UNION INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPEAN UNION INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPEAN UNION INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 102. BRICS INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. BRICS INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. BRICS INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. G7 INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. G7 INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. G7 INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. G7 INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. G7 INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 112. NATO INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. NATO INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NATO INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. NATO INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. NATO INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 123. CHINA INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. CHINA INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. CHINA INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)